You may remember I posted a while back about a submission we're making to NICE about making olaparib and bevacizumab (Avastin) available in combination as a maintenance therapy.
I asked for anyone who had experience of this (probably through the PAOLA-1 trial) who didn't mind sharing their experience to leave comments or contact me so that we can include this information in the submission.
Unfortunately no-one has contacted me, so I was wondering if those of you who have experienced these treatments singly would mind commenting on your experience?
I wouldn't use any identifying information in the submission, just your comment about your experience.
Using quotes from women who have experienced these treatments is so important, and makes our submission so much stronger.
Also if any of you have any comments on expanding the range of maintenance therapies available, I could include those.
Many thanks for your help as always.
Head of Ovacome Support Services